These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29127450)

  • 1. Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods.
    Casati S; Aschberger K; Barroso J; Casey W; Delgado I; Kim TS; Kleinstreuer N; Kojima H; Lee JK; Lowit A; Park HK; Régimbald-Krnel MJ; Strickland J; Whelan M; Yang Y; Zuang V
    Arch Toxicol; 2018 Feb; 92(2):611-617. PubMed ID: 29127450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardisation and international adoption of defined approaches for skin sensitisation.
    Casati S; Asturiol D; Browne P; Kleinstreuer N; Régimbald-Krnel M; Therriault P
    Front Toxicol; 2022; 4():943152. PubMed ID: 36032790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
    Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
    Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying non-animal strategies for assessing skin sensitisation report from an EPAA/cefic-LRI/IFRA Europe cross sector workshop, ECHA helsinki, February 7th and 8th 2019.
    Basketter D; Azam P; Casati S; Corvaro M; Ezendam J; Griem P; Hubesch B; Irizar A; Kern P; Manou I; Mehling A; Rossi LH
    Regul Toxicol Pharmacol; 2019 Dec; 109():104477. PubMed ID: 31586681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshop.
    Ramirez T; Beken S; Chlebus M; Ellis G; Griesinger C; De Jonghe S; Manou I; Mehling A; Reisinger K; Rossi LH; van Benthem J; van der Laan JW; Weissenhorn R; Sauer UG
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):210-26. PubMed ID: 26188116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Approaches to Testing and Assessment.
    Casati S
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():51-55. PubMed ID: 29604238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local tolerance testing under REACH: Accepted non-animal methods are not on equal footing with animal tests.
    Sauer UG; Hill EH; Curren RD; Raabe HA; Kolle SN; Teubner W; Mehling A; Landsiedel R
    Altern Lab Anim; 2016 Jul; 44(3):281-99. PubMed ID: 27494627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.
    Basketter D; Alépée N; Casati S; Crozier J; Eigler D; Griem P; Hubesch B; de Knecht J; Landsiedel R; Louekari K; Manou I; Maxwell G; Mehling A; Netzeva T; Petry T; Rossi LH
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):531-5. PubMed ID: 24140884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
    Spielmann H; Liebsch M
    Toxicol In Vitro; 2001; 15(4-5):585-90. PubMed ID: 11566595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adverse outcome pathway for skin sensitisation: Moving closer to replacing animal testing.
    Schultz TW; Dimitrova G; Dimitrov S; Mekenyan OG
    Altern Lab Anim; 2016 Oct; 44(5):453-460. PubMed ID: 27805828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International regulatory requirements for skin sensitization testing.
    Daniel AB; Strickland J; Allen D; Casati S; Zuang V; Barroso J; Whelan M; Régimbald-Krnel MJ; Kojima H; Nishikawa A; Park HK; Lee JK; Kim TS; Delgado I; Rios L; Yang Y; Wang G; Kleinstreuer N
    Regul Toxicol Pharmacol; 2018 Jun; 95():52-65. PubMed ID: 29518484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Harmonization and Cooperation in the Validation of Alternative Methods.
    Barroso J; Ahn IY; Caldeira C; Carmichael PL; Casey W; Coecke S; Curren R; Desprez B; Eskes C; Griesinger C; Guo J; Hill E; Roi AJ; Kojima H; Li J; Lim CH; Moura W; Nishikawa A; Park H; Peng S; Presgrave O; Singer T; Sohn SJ; Westmoreland C; Whelan M; Yang X; Yang Y; Zuang V
    Adv Exp Med Biol; 2016; 856():343-386. PubMed ID: 27671730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harmonisation of animal testing alternatives in China.
    Cheng S; Qu X; Qin Y
    Altern Lab Anim; 2017 Dec; 45(6):333-338. PubMed ID: 29313705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
    Stokes WS; Schechtman LM; Hill RN
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International regulatory uses of acute systemic toxicity data and integration of new approach methodologies.
    Strickland J; Haugabrooks E; Allen DG; Balottin LB; Hirabayashi Y; Kleinstreuer NC; Kojima H; Nishizawa C; Prieto P; Ratzlaff DE; Jeong J; Lee J; Yang Y; Lin P; Sullivan K; Casey W
    Crit Rev Toxicol; 2023 Aug; 53(7):385-411. PubMed ID: 37646804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
    Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
    Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory acceptance of alternatives in the European Union.
    Warbrick EV; Evans PF
    Altern Lab Anim; 2004 Jun; 32 Suppl 1B():657-61. PubMed ID: 23581154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of peptide reactivity assays for skin sensitisation hazard identification and risk assessment.
    Gerberick GF
    Altern Lab Anim; 2016 Oct; 44(5):437-442. PubMed ID: 27805826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies.
    Ezendam J; Braakhuis HM; Vandebriel RJ
    Arch Toxicol; 2016 Dec; 90(12):2861-2883. PubMed ID: 27629427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
    Spielmann H
    Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.